InvestorsHub Logo
icon url

CWS1987

12/10/15 11:43 AM

#77919 RE: codie #77918

Obviously neither dumped the other. The deal came to an end and MusclePharm decided it wasn't worth it to re-up. It will be interesting to see who becomes the new "official supplement provider". I wonder if Nutrabolt/Glanbia/etc. will find the value compelling enough to pay what I imagine will be a very hefty premium.

In general, the letter is a pleasant surprise. It finally seems like an adult is in charge of the company. The change from stock grants to stock option is particularly compelling, but it remains to be seen just how much supply chain efficiency they can ring out - and, of course, how quickly. There's no reason they couldn't be fully contract-manufacturing-dependent and still profitable, especially if they quickly roll down the endorsements and gratuitous executive compensation. Time will tell. I don't think this explanation is enough to make MSLP a compelling buy, but the company certainly seems to be in a better position than it was yesterday.
icon url

bajista

12/10/15 12:26 PM

#77923 RE: codie #77918

Musclepharm, with their limited amount of cash, found a way to get a better bang for their marketing dollars and chose not to continue the relationship and opted to still be present in that particular market segment by sponsoring their own team. Nice try.